Trump orders more access to psychedelics like LSD, psilocybin, ibogaine - The Washington Post

The Washington Post
April 18, 2026
4 views
2 min read

Quick Insights

The Bottom Line

President Donald Trump ordered increased access to psychedelics like LSD, psilocybin, and ibogaine.

How This Affects You

This directive could facilitate new treatments for mental health conditions by expanding the availability of psychedelics for therapeutic or research purposes.

AI Summary

President Donald Trump has ordered increased access to psychedelics such as LSD, psilocybin, and ibogaine. This directive aims to expand the availability of these substances, which are currently largely illegal, for therapeutic or research purposes. The move signals a significant shift in federal policy regarding controlled substances, potentially facilitating new treatments for mental health conditions. This decision could accelerate research into the medical benefits of psychedelics and influence future regulatory frameworks. The order from the White House reflects a growing interest in the potential of these compounds beyond their recreational use.

Source Coverage Map

13 of 43 tracked sources covered this story

30% coverage
Did Not Cover (30)
ICIJ97AP World News96AP US News96AP Top News96ProPublica95+25 more

Following this story?

Get notified when new coverage appears

Story Tracker

This article is part of a story we're tracking:

Trump's Influence on US Politics and Foreign Policy

Former President Donald Trump continues to exert significant influence on US politics, from taunting foreign leaders and shaping primary elections to making controversial statements on immigration and foreign policy, including his stance on the ongoing Iran conflict.

Trump Administration Actions and Policies

The Trump administration is taking various actions, including restarting the Global Entry program, pushing for college sports legislation, and facing scrutiny over its handling of the Iran conflict and its impact on the State Department.

Trump Administration's Policies and Political Landscape

The Trump administration continues to face scrutiny over its policies, including efforts to support coal plants and a controversial settlement in a predatory lending case. Simultaneously, discussions about invoking the 25th Amendment and limiting the President's powers are gaining traction among Democrats, while some former allies express criticism.

Trump Administration's Push for Psychedelic Drug Treatments

President Donald Trump has signed an executive order to accelerate access to and research into psychedelic drug treatments. This move aims to expand the availability of substances like LSD, psilocybin, and ibogaine for mental health treatment and research.

Trump Administration's Psychedelic Drug Initiative

President Trump signed an executive order to accelerate access to psychedelic drug treatments and research for mental health. This initiative aims to expand the availability of substances like LSD, psilocybin, and ibogaine for medical use.

Trump's Executive Order on Psychedelic Research

President Trump signed an executive order to ease restrictions and accelerate research into psychedelics, including ibogaine, LSD, and psilocybin, for mental health treatments. This move aims to expand access to these substances and expedite their review process.

Trump's Psychedelics Research Initiative

President Trump signed an executive order to ease restrictions and accelerate research into psychedelics like ibogaine, LSD, and psilocybin for potential medical applications, particularly in mental health treatment. The initiative aims to expand access to these substances and expedite their review process.

Trump's Executive Order on Psychedelic Research

President Trump signed an executive order aimed at accelerating the federal review process for psychedelics. The order seeks to expand access to psychedelic drug treatments for mental health, specifically mentioning substances like ibogaine, LSD, and psilocybin.

Trump Administration Accelerates Psychedelic Drug Research

President Donald Trump has signed an executive order to fast-track the review and research of psychedelic drugs for mental health disorders. This move aims to accelerate access to treatments like psilocybin and ibogaine, with the President publicly endorsing their potential.

Trump Administration Accelerates Psychedelic Drug Research

President Donald Trump signed an executive order to accelerate research and review of psychedelic drugs like psilocybin and ibogaine for mental health treatments. This move aims to fast-track their potential medical applications, with figures like Joe Rogan joining the announcement.

Trump Administration's Psychedelic Drug Research Initiative

President Trump has signed an executive order to accelerate research and review of psychedelic drugs for mental health disorders, including psilocybin and ibogaine. This initiative aims to expand access to these therapies, with podcaster Joe Rogan reportedly influencing the decision.

Trump Executive Order on Psychedelic Drug Research

President Trump signed an executive order to accelerate research and access to psychedelic drug treatments for mental health disorders. The initiative aims to fast-track the review process for substances like psilocybin and ibogaine.

Should this be getting more attention?

You Might Have Missed

Related stories from different sources and perspectives

Justice Jackson chides Supreme Court conservatives over 'oblivious' pro-Trump emergency orders - AP News
Politics

Justice Jackson chides Supreme Court conservatives over 'oblivious' pro-Trump emergency orders - AP News

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSmh3bjRzUnc2ZS1wb19KQ3d1eUtfTS1KX1M1anctNDVhSWo3aF83NWNpOXRJV2hiYmc3aEgzUkNxekJmSlJfVlN4UVg4VTQ3M0txVDVfRld2NnI4S3hpZGZNX01ZRjhyeHFOZ29nTW9SeDQ5RkdBSVlpNHlSeklMbVFDX3YybkkzQnN3dHZ3SC1tUzBxR3JiSm1FVGdrUmQ3RFFPNUtjZkhXczlqNlJhaklXZEtJUlJPYVpn?oc=5" target="_blank">Justice Jackson chides Supreme Court conservatives over 'oblivious' pro-Trump emergency orders</a>&nbsp;&nbsp;<font color="#6f6f6f">AP News</font>

AP NewsApr 15
Trump adviser Sebastian Gorka seeks top counterterrorism job - The Washington Post
National Security

Trump adviser Sebastian Gorka seeks top counterterrorism job - The Washington Post

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxOb0JjSGRVV3RkZjZncG8yRUJvRER3b0pySHQyTnBxcWtxQkVyRHV1d1dXUnlFLUdlaTVRUnJMS2J5RGFWWTVJS09iZVpscUtIamt6QS1uSGhiRUxCWTZmcUN6RTlXZlhLMmhmWFlVVFYyTnlYMTl4MDN3VmtxWnZQSGcyZG1zSUFWTW9PRmN5ajNvLXdiTGFqQnU0SENUYnVJdWc?oc=5" target="_blank">Trump adviser Sebastian Gorka seeks top counterterrorism job</a>&nbsp;&nbsp;<font color="#6f6f6f">The Washington Post</font><strong><a href="https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZjbmt0TXpZd1NoRUtEd2pnc2N2MUVCRnNvLWJXY0FmRnppZ0FQAQ?hl=en-US&gl=US&ceid=US:en&oc=5" target="_blank">View Full Coverage on Google News</a></strong>

The Washington PostApr 15
Syrian Billionaires Needed a Favor in Washington. They Invoked the Trump Name.
Politics

Syrian Billionaires Needed a Favor in Washington. They Invoked the Trump Name.

The attempt by the Khayyats to influence foreign policy while discussions are underway about potential Trump family deals is an increasingly common feature of the president’s second term.

New York TimesApr 19
FDA Commissioner Marty Makary breaks down Trump's executive order on psychedelics
Health

FDA Commissioner Marty Makary breaks down Trump's executive order on psychedelics

President Trump has signed an executive order to expand research into psychedelic drugs for mental health treatment. Dr. Marty Makary, commissioner of the Food and Drug Administration, joins CBS News to discuss.

CBS NewsApr 20
DOJ accuses Biden administration of weaponizing abortion access law - The Washington Post
Politics

DOJ accuses Biden administration of weaponizing abortion access law - The Washington Post

The Washington PostApr 15
Trump's border wall lurches closer to schedule
Politics

Trump's border wall lurches closer to schedule

<p>The U.S. has built roughly 50 miles of <a href="https://www.axios.com/2026/02/03/noem-dhs-border-wall-construction-contracts" target="_blank">primary border wall</a> along the southern border, 5.5 miles of buoy barriers in the water and 13.2 miles of secondary barriers, Customs and Border Protection commissioner Rodney Scott told Congress on Thursday.</p><p><strong>Why it matters:</strong> The $46 billion project has been stalled by contracting issues and community <a href="https://www.axios.com/2026/04/09/trump-border-wall-big-bend-texas-mexico" target="_blank">resistance</a>. But Scott told Congress the effort is now "ahead of schedule and we're below budget."</p><hr><p><strong>By the numbers: </strong>The agency anticipated that it could build about 10 miles of wall per week, according to an interview with the <a href="https://www.washingtonexaminer.com/news/investigations/4444838/dhs-officials-point-fingers-delay-border-wall-construction/?utm_source=chatgpt.com" target="_blan...

AxiosApr 16
Read Next
Trump labor secretary Lori Chavez-DeRemer resigns amid misconduct investigation - The Guardian
Politics

Trump labor secretary Lori Chavez-DeRemer resigns amid misconduct investigation - The Guardian

Continue reading

Did this story change how you see things?

Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.

Share this story

Get the daily digest

Save for later

The Verity Ledger curates verified investigative journalism from trusted sources only.

See our sources